{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:35:52Z","timestamp":1791549352858,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,3,29]],"date-time":"2006-03-29T00:00:00Z","timestamp":1143590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1007\/s00228-005-0084-9","type":"journal-article","created":{"date-parts":[[2006,3,28]],"date-time":"2006-03-28T05:47:34Z","timestamp":1143524854000},"page":"335-341","source":"Crossref","is-referenced-by-count":39,"title":["Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects"],"prefix":"10.1007","volume":"62","author":[{"given":"Daniel","family":"R\u00f6shammar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinh Ngoc","family":"Hai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Friberg Hietala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen","family":"Van Huong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,3,29]]},"reference":[{"key":"84_CR1","first-page":"281","volume":"95","author":"L Chen","year":"1982","unstructured":"Chen L, Qu FY, Zhou YC (1982) Field observations on the antimalarial piperaquine. Chin Med J (Engl) 95:281\u2013286","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"84_CR2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00003495-200565010-00004","volume":"65","author":"TME Davis","year":"2005","unstructured":"Davis TME, Hung TY, Sim IK, Karunajeewa HA, Ilett KF (2005) Piperaquine: a resurgent antimalarial drug. Drugs 65(1):75\u201387","journal-title":"Drugs"},{"issue":"10","key":"84_CR3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0169-4758(96)10055-7","volume":"12","author":"NJ White","year":"1996","unstructured":"White NJ, Olliaro PL (1996) Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. Parasitol Today 12(10): 399\u2013401 DOI 10.1016\/0169\u20134758(96)10055\u20137","journal-title":"Parasitol Today"},{"issue":"1\u20133","key":"84_CR4","first-page":"308","volume":"41","author":"NJ White","year":"1999","unstructured":"White NJ (1999) Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia 41(1\u20133):310\u2013308","journal-title":"Parassitologia"},{"key":"84_CR5","unstructured":"World Health Organization (2001) Antimalarial Drug Combination Therapy. Report of a WHO Technical Consultation (35)"},{"issue":"2","key":"84_CR6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4269\/ajtmh.2004.71.179","volume":"71","author":"S Yeung","year":"2004","unstructured":"Yeung S, Pongtavornpinyo W, Hastings IM, Mills AJ, White NJ (2004) Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. Am J Trop Med Hyg 71(2):179\u2013186","journal-title":"Am J Trop Med Hyg"},{"key":"84_CR7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(03)15163-X","volume":"363","author":"TT Hien","year":"2003","unstructured":"Hien TT, Dolecek C, Mai PP, Dung NT, Truong NT, Thai LH, An DTH, Thanh TT, Stepniewska K, White NJ, Farrar J (2003) Dihydroartemisinin-piperaquine against multidrug-resistant plasmodium falciparum malaria in Vietnam: randomized clinical trial. Lancet 363:18\u201322. DOI 10.1016\/S0140\u20136736(03)15163\u2013X","journal-title":"Lancet"},{"key":"84_CR8","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1086\/344647","volume":"35","author":"BM Denis","year":"2002","unstructured":"Denis BM, Davis MET, Hewitt S, Incardona S, Nimol K, Fandeur T, Poravuth Yi, Lim C, Socheat D (2002) Efficacy and safety of dihydroartemisinine-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clin Infect Dis 35:1469\u20131476. DOI 1058\u20134838\/2002\/3512\u20130003","journal-title":"Clin Infect Dis"},{"issue":"1","key":"84_CR9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2125.2003.01962.x","volume":"57","author":"H Karunajeewa","year":"2003","unstructured":"Karunajeewa H, Lim C, Hung TY, Ilett KF, Denis MB, Socheat D, Davis TME (2003) Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria. Br J Clin Pharmacol 57(1):93\u201399. DOI 10.1046\/j.1365\u20132125.2003.01962.x","journal-title":"Br J Clin Pharmacol"},{"key":"84_CR10","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1086\/425015","volume":"190","author":"EA Ashley","year":"2004","unstructured":"Ashley EA, Krudsood S, Phaiphun L, Srivilairit S, McGready R, Leowattana W, Hutagalung R, Wilairatana P, Brockman A, Looareesuwan S, Nosten F, White NJ (2004) Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. J Infect Dis 190:1773\u20131782. DOI 0022\u20131899\/2004\/19010\u20130009","journal-title":"J Infect Dis"},{"issue":"3","key":"84_CR11","first-page":"519","volume":"33","author":"P Wilairatana","year":"2002","unstructured":"Wilairatana P, Krudsood S, Chalermrut K, Pengruksa C, Srivilairit S, Silachamroon U, Treeprasertuk S, Looareesuwan S (2002) An open randomized clinical trial of Artecom vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand. Southeast Asian J Trop Med Public Health 33(3):519\u2013524","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"2","key":"84_CR12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-3156.2003.01180.x","volume":"9","author":"PT Giao","year":"2004","unstructured":"Giao PT, de Vries PJ, Hung LQ, Binh TQ, Nam NV, Kager PA (2004) CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam. Trop Med Int Health 9(2):209\u2013216. DOI 10.1046\/j.1365\u20133156.2003.01180.x","journal-title":"Trop Med Int Health"},{"key":"84_CR13","first-page":"19","volume":"8","author":"Q Chen","year":"1979","unstructured":"Chen Q, Deng J, Wu D (1979) Study on absorption, distribution and excretion of 14C-piperaquine phosphate and 14C-piperaquine in mice. Pharm Ind 8:19\u201323","journal-title":"Pharm Ind"},{"key":"84_CR14","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1128\/AAC.49.6.2407-2411.2005","volume":"49","author":"IK Sim","year":"2005","unstructured":"Sim IK, Davis TME, Ilett KF (2005) Effects of a high-fat meal on the relative oral bioavailability of piperaquine. Antimicrob Agents Chemother 49: 2407\u20132411","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"84_CR15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1365-2125.2003.02004.x","volume":"57","author":"T Hung","year":"2003","unstructured":"Hung T, Davis T, Ilett K, Karunajeewa H, Hewitt S, Denis MB, Lim C, Socheat D (2003) Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria. Br J Clin Pharmacol 57(3):253\u2013262. DOI 10.1046\/j.1365\u20132125.2003.02004.x","journal-title":"Br J Clin Pharmacol"},{"key":"84_CR16","first-page":"1","volume":"40","author":"N Lindeg\u00e5rdh","year":"2003","unstructured":"Lindeg\u00e5rdh N, Ashton M, Bergqvist Y (2003) Automated solid-phase extraction method for the determination of piperaquine in plasma by peak compression liquid chromatography. J Chromatogr Sci 40:1\u20136","journal-title":"J Chromatogr Sci"},{"key":"84_CR17","unstructured":"Beal SL, Boeckman AJ, Sheiner LB (1992) NONMEM Users Guides. NONMEM Project Group, University of California at San Fransisco, San Fransisco"},{"key":"84_CR18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","volume":"58","author":"EN Jonsson","year":"1999","unstructured":"Jonsson EN, Karlsson MO (1999) Xpose-an S-PLUS based population pharmacokinetic\/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed 58:51\u201364. DOI 10.1016\/S0169\u20132607(98)00067\u20134","journal-title":"Comput Methods Programs Biomed"},{"issue":"6","key":"84_CR19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/BF01113502","volume":"21","author":"MO Karlsson","year":"1993","unstructured":"Karlsson MO, Sheiner LB (1993) The importance of modeling interoccasion variability in population pharmacokinetic analyses. J Pharmacokinet Biopharm 21(6):735\u2013750","journal-title":"J Pharmacokinet Biopharm"},{"key":"84_CR20","first-page":"195","volume":"8","author":"SL Beal","year":"1982","unstructured":"Beal SL, Sheiner LB (1982) Estimating population kinetics. Crit Rev Biomed Eng 8:195\u2013222","journal-title":"Crit Rev Biomed Eng"},{"key":"84_CR21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/0091270002250613","volume":"43","author":"H Zhou","year":"2003","unstructured":"Zhou H (2003) Pharmacokinetic strategies in deciphering atypical drug absorption profiles. J Clin Pharmacol 43:211\u2013227. DOI 10.1177\/0091270002250613","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"84_CR22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF01061761","volume":"15","author":"RL Oberle","year":"1987","unstructured":"Oberle RL, Amidon GL (1987) The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine: an explanation for the double peak phenomenon. J Pharmacokinet Biopharm 15(5):529\u2013544","journal-title":"J Pharmacokinet Biopharm"},{"key":"84_CR23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2125.1996.04231.x","volume":"42","author":"RC Schoemaker","year":"1996","unstructured":"Schoemaker RC, Cohen AF (1996) Estimating impossible curves using NONMEM. Br J Clin Pharmacol 42:283\u2013290","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"84_CR24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1011527125570","volume":"28","author":"U Wahlby","year":"2001","unstructured":"Wahlby U, Jonsson EN, Karlsson MO (2001) Assessment of actual significance levels for covariate effects in NONMEM. J Pharmacokinet Pharmacodyn 28(3):231\u2013252. DOI 10.1023\/A:1011527125570","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"3","key":"84_CR25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1020254823597","volume":"29","author":"U Wahlby","year":"2002","unstructured":"Wahlby U, Bouw MR, Jonsson EN, Karlsson MO (2002) Assessment of type I error rates for the statistical sub-model in NONMEM. J Pharmacokinet Pharmacodyn 29(3):251\u2013269. DOI 10.1023\/A:1020254823597","journal-title":"J Pharmacokinet Pharmacodyn"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-005-0084-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-005-0084-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-005-0084-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T08:51:21Z","timestamp":1558687881000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-005-0084-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,29]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["84"],"URL":"https:\/\/doi.org\/10.1007\/s00228-005-0084-9","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,29]]}}}